Rein Therapeutics, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Rein Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from 2018 to 2023.
  • Rein Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $13K, a 13.3% decline year-over-year.
  • Rein Therapeutics, Inc. annual Depreciation for 2023 was $49K, a 71% decline from 2022.
  • Rein Therapeutics, Inc. annual Depreciation for 2022 was $169K, a 39.7% increase from 2021.
  • Rein Therapeutics, Inc. annual Depreciation for 2021 was $121K, a 25.8% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $49K -$120K -71% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 $169K +$48K +39.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 $121K -$42K -25.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $163K +$23K +16.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $140K -$78K -35.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 $218K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.